The efficacy of hyperthemia integrated with transcatheter hepatic artery chemoembolization in treatment of primary liver cancer

Objective To observe the efficacy of hyperthermia integrated with transcatheter hepatic artery chemoembolization in the treatment of primary liver cancer.Methods Fifty-five cases of primary liver cancer were randomized into two groups:group A(n=24) with treatment of hyperthermia combined with transcatheter hepatic artery chemoembolization and group B(n=31) with treatment of transcatheter hepatic artery chemoembolization alone.The effects and survival rates of 1,2 years were compared in two groups. Results The effect rate in group A was higher than that in group B (83.3% vs 58.1%,P0.05).In group A,The survival rates of 1,2years were 79.2%(19/24) and 50.0%(12/24) respectively;in group B,the survival rates of 1,2 years were 61.3%(19/31) and 16.1%(5/31) respectively.Survival rates of 1-year had no difference in two groups(P0.05),but survival rate of 2-year in group A was higher than that in group B (P0.05).Compared with group B,there was no increasing of adverse effects in group A.Conclusions Hyperthermia combined with transcatheter hepatic artery chemoembolization for primary liver cancer is a safe and effective regimen,and is worthy of promotion and further study.